{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:44:01Z","timestamp":1740145441982,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["COV20\/00470"],"award-info":[{"award-number":["COV20\/00470"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","revespcardiol.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.rec.2023.12.004","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T09:29:37Z","timestamp":1704533377000},"page":"539-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study"],"prefix":"10.1016","volume":"77","author":[{"given":"\u00c1ngela","family":"Prieto-Campo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maruxa","family":"Zapata-Cachafeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Portela-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Pi\u00f1eiro-Lamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Figueiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Salgado-Barreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2023.12.004_bib0185","unstructured":"COVID-19 Data Explorer. Our World in Data. Available at: https:\/\/ourworldindata.org\/explorers\/coronavirus-data-explorer. 2019. Accessed 8 Feb 2023."},{"key":"10.1016\/j.rec.2023.12.004_bib0190","unstructured":"UN News. Global perspective Human stories. Available at: https:\/\/news.un.org\/en\/. Accessed 8 Feb 2023."},{"key":"10.1016\/j.rec.2023.12.004_bib0195","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/jth.15517","article-title":"Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis","volume":"19","author":"Chow","year":"2021","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rec.2023.12.004_bib0200","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijcard.2021.09.058","article-title":"Pre-admission acetylsalicylic acid therapy and impact on in-hospital outcome in COVID-19 patients: The ASA-CARE study","volume":"344","author":"Sisinni","year":"2021","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2023.12.004_bib0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/heartjnl-2021-319552","article-title":"Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry","volume":"108","author":"Santoro","year":"2022","journal-title":"Heart."},{"key":"10.1016\/j.rec.2023.12.004_bib0210","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41401-022-00998-0","article-title":"Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies","volume":"44","author":"Xu","year":"2023","journal-title":"Acta Pharmacol Sin."},{"key":"10.1016\/j.rec.2023.12.004_bib0215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ajem.2021.01.016","article-title":"Effect of antiplatelet treatments on patients with COVID-19 infection: A systematic review and meta-analysis","volume":"43","author":"Wang","year":"2021","journal-title":"Am J Emerg Med."},{"key":"10.1016\/j.rec.2023.12.004_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2021.08.012","article-title":"The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia","volume":"32","author":"Iba","year":"2022","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.rec.2023.12.004_bib0225","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11239-021-02383-w","article-title":"Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients","volume":"52","author":"Ho","year":"2021","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.rec.2023.12.004_bib0230","doi-asserted-by":"crossref","first-page":"989903","DOI":"10.3389\/fphar.2022.989903","article-title":"Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis","volume":"13","author":"Su","year":"2022","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.rec.2023.12.004_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19","volume":"326","author":"Connors","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2023.12.004_bib0240","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11239-021-02507-2","article-title":"Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19","volume":"53","author":"Corrochano","year":"2022","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.rec.2023.12.004_bib0245","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1358863X20932640","article-title":"COVID\u201319-associated coagulopathy: An exploration of mechanisms","volume":"25","author":"Colling","year":"2020","journal-title":"Vasc Med."},{"key":"10.1016\/j.rec.2023.12.004_bib0250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11239-021-02436-0","article-title":"Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis","volume":"52","author":"Kow","year":"2021","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.rec.2023.12.004_bib0255","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.arbres.2022.07.017","article-title":"Prehospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS)","volume":"58","author":"Lal","year":"2022","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.rec.2023.12.004_bib0260","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.hrtlng.2021.04.010","article-title":"Prehospital antiplatelet medication use on COVID-19 disease severity","volume":"50","author":"Pan","year":"2021","journal-title":"Heart Lung."},{"key":"10.1016\/j.rec.2023.12.004_bib0265","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5492\/wjccm.v11.i2.92","article-title":"Retrospective analysis of aspirin's role in the severity of COVID-19 pneumonia","volume":"11","author":"Gogtay","year":"2022","journal-title":"World J Crit Care Med."},{"key":"10.1016\/j.rec.2023.12.004_bib0270","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood.2020006941","article-title":"Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study","volume":"136","author":"Tremblay","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.rec.2023.12.004_bib0275","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/joim.13205","article-title":"Direct oral anticoagulant use and risk of severe COVID-19","volume":"289","author":"Flam","year":"2021","journal-title":"J Intern Med."},{"key":"10.1016\/j.rec.2023.12.004_bib0280","series-title":"Encyclopedia;1; of Quantitative Risk Analysis and Assessment. 3a ed.","first-page":"194","article-title":"Case\u2013Control Studies","author":"Rothman","year":"2008"},{"key":"10.1016\/j.rec.2023.12.004_bib0285","doi-asserted-by":"crossref","first-page":"i969","DOI":"10.1136\/bmj.i969","article-title":"Analysis of matched case-control studies","volume":"352","author":"Pearce","year":"2016","journal-title":"BMJ."},{"key":"10.1016\/j.rec.2023.12.004_bib0290","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. EU Electronic Register of Post-Authorisation Studies. Available at: https:\/\/www.encepp.eu\/encepp\/viewResource.htm?id=44588. Accessed 8 Feb 2023."},{"key":"10.1016\/j.rec.2023.12.004_bib0295","doi-asserted-by":"crossref","DOI":"10.2202\/1557-4679.1127","article-title":"Why Match? Investigating Matched Case-Control Study Designs with Causal Effect Estimation","volume":"5","author":"Rose","year":"2009","journal-title":"Int J Biostat."},{"key":"10.1016\/j.rec.2023.12.004_bib0300","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1186\/1471-2458-13-1030","article-title":"Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications","volume":"13","author":"Huber","year":"2013","journal-title":"BMC Public Health."},{"key":"10.1016\/j.rec.2023.12.004_bib0305","series-title":"Applied Mixed Models in Medicine.","first-page":"120","author":"Brown","year":"2006"},{"key":"10.1016\/j.rec.2023.12.004_bib0310","series-title":"Mixed-Effects Models in S and S-PLUS","first-page":"3","author":"Pinheiro","year":"2006"},{"key":"10.1016\/j.rec.2023.12.004_bib0315","unstructured":"Generalized Linear Mixed Models: Modern Concepts, Methods and Applications. Routledge & CRC Press. Available at: https:\/\/www.routledge.com\/Generalized-Linear-Mixed-Models-Modern-Concepts-Methods-and-Applications\/Stroup\/p\/book\/9781439815120. Accessed 8 Feb 2023."},{"key":"10.1016\/j.rec.2023.12.004_bib0320","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.medcli.2021.03.027","article-title":"Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area","volume":"25","author":"Satu\u00e9-Gracia","year":"2022","journal-title":"Spain. Med Clin."},{"key":"10.1016\/j.rec.2023.12.004_bib0325","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1111\/febs.15784","article-title":"The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID-19 infection","volume":"288","author":"Merzon","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.rec.2023.12.004_bib0330","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3349\/ymj.2015.56.5.1227","article-title":"Effect of Triflusal on Primary Vascular Dysregulation Compared with Aspirin: A Double-Blind, Randomized","volume":"56","author":"Shin","year":"2015","journal-title":"Crossover Trial. Yonsei Med J."},{"key":"10.1016\/j.rec.2023.12.004_bib0335","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2165\/00003495-200666050-00009","article-title":"Triflusal: a review of its use in cerebral infarctino and myocardial infarction, and as thromboprophylaxis in atrial fibrillation","volume":"66","author":"Murdoch","year":"2006","journal-title":"Drugs."},{"key":"10.1016\/j.rec.2023.12.004_bib0340","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. FICHA TECNICA TRIFLUSAL FARMALIDER 300mg CAPSULAS DURAS EFG. Available at: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/65247\/FT_65247.html. Accessed 8 Feb 2023."},{"key":"10.1016\/j.rec.2023.12.004_bib0345","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. FICHA TECNICA A.A.S. 100mg COMPRIMIDOS. Available at: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/42991\/FichaTecnica_42991.html. Accessed 8 Feb 2023."},{"key":"10.1016\/j.rec.2023.12.004_bib0350","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijid.2021.07.007","article-title":"Drug exposure may have a substantial influence on COVID-19 prognosis among residents of long-term care facilities: an exploratory analysis","volume":"109","author":"Soldevila","year":"2021","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.rec.2023.12.004_bib0355","first-page":"199","article-title":"Triflusal: an old drug in modern antiplatelet therapy Review of its action, use, safety and effectiveness","volume":"50","author":"Anninos","year":"2009","journal-title":"Hellenic J Cardiol."},{"key":"10.1016\/j.rec.2023.12.004_bib0360","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/pds.5109","article-title":"Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence","volume":"29","author":"Hall","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T04:30:32Z","timestamp":1719462632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585724000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1885585724000148"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2023.12.004","relation":{},"ISSN":["1885-5857"],"issn-type":[{"type":"print","value":"1885-5857"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2023.12.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}